Release Date: 28/07/20 09:44 Summary: POTENTIAL ACQUISITION OF GORO PRESENTATION Price Sensitive: Yes Download Document 6.12MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%